6-溴-2H-异喹啉-1-酮 | 82827-09-6

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 6-溴-2H-异喹啉-1-酮
• 中文别名: 6-溴异喹啉-1-酮；6-溴异喹啉-1(2H)-酮；6-溴-1-羟基异喹啉
• 英文名称: 6-bromo-2H-isoquinoline-1-one
• 英文别名: 6-bromoisoquinolin-1(2H)-one；6-bromo-2H-isoquinolin-1-one；6-bromo-1,2-dihydro-1-oxoisoquinoline
• CAS: 82827-09-6
• 化学式: C₉H₆BrNO
• mdl: MFCD07374394
• 分子量: 224.057
• InChiKey: ZDYXSEQHOVSTPA-UHFFFAOYSA-N

物化性质

• 沸点：
  442.6±45.0 °C(Predicted)
• 密度：
  1.620±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933790090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Bromoisoquinolin-1-ol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Bromoisoquinolin-1-ol
CAS number: 82827-09-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H6BrNO
Molecular weight: 224.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

医药中间体

反应信息

• 作为反应物：
  描述：

  6-溴-2H-异喹啉-1-酮 在 tris-(dibenzylideneacetone)dipalladium(0) 二苯甲酮亚胺 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 sodium t-butanolate 、 甲醇 、 盐酸羟胺 、 sodium acetate 作用下， 以 甲苯 为溶剂， 反应 144.0h， 以90%的产率得到6-氨基异喹啉-1(2H)-酮
  参考文献：
  名称：

  WO2008/157162

  摘要：

  公开号：
• 作为产物：
  描述：

  6-溴异喹啉 在 甲基磺酰氯 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 24.0h， 生成 6-溴-2H-异喹啉-1-酮
  参考文献：
  名称：

  光诱导的[2 + 2]环加成反应，用于构建环丁烷稠合的吡啶基磺酰氟。

  摘要：

  环戊烯酮是存在于多种天然产物和其他生物学上重要分子中的重要基序类。实现了吡啶酮或异喹啉酮与乙磺酰氟之间的光催化[2 + 2]环加成反应，为一类独特的带有季刚性环的稠合环丁烷的吡啶基磺酰氟提供了一个门户（30个例子）。还完成了这些新型磺酰氟分子在SuFEx点击化学中的进一步应用，以合理的产率提供了相应的磺酸盐和磺酰胺。

  DOI：

  10.1039/d0ob00814a
• 作为试剂：
  描述：

  6-溴异喹啉 、 间氯过氧苯甲酸 在 碳酸氢钠 、 氯化铵 、 Brine 、 乙酸酐 、 sodium hydroxide 、 title compound 、 6-溴-2H-异喹啉-1-酮 作用下， 以 二氯甲烷 为溶剂， 反应 26.0h， 生成 6-溴-2H-异喹啉-1-酮
  参考文献：
  名称：

  Substituted arylalkanoic acid derivatives and use thereof

  摘要：

  化合物的化学式为（I）：[在该式中，Link代表具有1至3个碳原子的饱和或不饱和直链烃基，C2至C6在芳环（E）中独立代表构成环的碳原子，环构成碳原子中的一个可以被V取代，V代表氮原子或被Zx取代的碳原子，Zx代表具有1至4个碳原子的饱和烷基等，Rs代表-D-Rx等，D代表单键，氧原子等，Rx代表具有3至8个碳原子的饱和烷基等，AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环，Y代表氢原子、具有1至4个碳原子的低级烷基等]或其盐。提供了一种具有前列腺素产生抑制作用和白三烯产生抑制作用的化合物。

  公开号：

  US07470807B2

文献信息

• [EN] PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PYRAZOLOSPIROCÉTONE ACÉTL-COA CARBOXYLASE
  申请人：PFIZER

  公开号：WO2009144554A1

  公开（公告）日：2009-12-03

  The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.

  本发明提供了式(1)的化合物或所述化合物的药用可接受盐，其中R1、R2和R3如本文所述；其药物组合物；以及用于治疗通过抑制动物中的乙酰辅酶A羧化酶酶活性来调节的疾病、病症或障碍的使用方法。
• N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
  申请人：BAGLEY SCOTT WILLIAM

  公开号：US20110111046A1

  公开（公告）日：2011-05-12

  The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R 1 , R 2 , R 3 and R 4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.

  该发明提供了化合物I的化合物或其药用可接受的盐，其中R1、R2、R3和R4如本文所述；以及其药物组合物；以及在治疗受乙酰辅酶A羧化酶抑制调节的动物疾病、症状或紊乱中的使用。
• N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS
  申请人：Griffith David A.

  公开号：US20120108619A1

  公开（公告）日：2012-05-03

  The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R 1 , R 2 and R 3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.

  这项发明提供了化合物的化学式(I)或其药用可接受的盐；其中G是R1，R2和R3如本文所述；以及其药物组合物；以及在治疗受乙酰辅酶A羧化酶抑制调节的动物疾病、状况或紊乱中的使用。
• Divergent Synthesis of Isoquinolone and Isocoumarin Derivatives by the Annulation of Benzoic Acid with <i>N</i>-Vinyl Amide
  作者：Rui Sun、Xiao Yang、Qianggen Li、Ke Xu、Juan Tang、Xueli Zheng、Maolin Yuan、Haiyan Fu、Ruixiang Li、Hua Chen

  DOI：10.1021/acs.orglett.9b03638

  日期：2019.12.6

  A simple and efficient method for the synthesis of isoquinolone and isocoumarin derivatives is reported. The method for the first time provides a one-step divergent synthesis of important isoquinolone and isocoumarin skeletons from benzoic acid by switching the coupling partners. In addition, a reliable mechanism has been proposed on the basis of experimental investigations, including kinetic isotope

  报道了一种简单有效的合成异喹诺酮和异香豆素衍生物的方法。该方法首次通过切换偶联伙伴，从苯甲酸一步一步地合成了重要的异喹诺酮和异香豆素骨架。此外，在实验研究的基础上，提出了一种可靠的机制，包括动力学同位素效应实验，13C标记实验，时间跟踪实验和竞争实验，以及DFT计算研究。
• [EN] SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS<br/>[FR] BENZAZINONES SUBSTITUÉS À UTILISER EN TANT QUE COMPOSÉS ANTIBACTÉRIENS
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017098440A1

  公开（公告）日：2017-06-15

  The present invention relates to LpxC antibacterial compounds of Formula (1A), corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions:, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

  该发明涉及Formula (1A)的LpxC抗菌化合物，其相应的药学上可接受的盐，相应的药物组合物，化合物制备，细菌感染的治疗方法和用途，特别是由革兰氏阴性细菌引起的感染。